INDEGENE
|
INDEGENE Last 5 Year Income Statement History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
INCOME : | |||||
Gross Sales | ₹2,590 Cr | ₹2,306 Cr | ₹1,665 Cr | ₹966 Cr | ₹643 Cr |
Sales | - | - | - | - | - |
Job Work/ Contract Receipts | - | - | - | - | - |
Processing Charges / Service Income | ₹2,590 Cr | ₹2,306 Cr | ₹1,665 Cr | ₹966 Cr | ₹643 Cr |
Revenue from property development | - | - | - | - | - |
Other Operational Income | - | - | - | - | - |
Less: Excise Duty | - | - | - | - | - |
Net Sales | ₹2,590 Cr | ₹2,306 Cr | ₹1,665 Cr | ₹966 Cr | ₹643 Cr |
EXPENDITURE : | |||||
Increase/Decrease in Stock | - | - | - | - | - |
Raw Material Consumed | - | - | - | - | - |
Opening Raw Materials | - | - | - | - | - |
Purchases Raw Materials | - | - | - | - | - |
Closing Raw Materials | - | - | - | - | - |
Other Direct Purchases / Brought in cost | - | - | - | - | - |
Other raw material cost | - | - | - | - | - |
Power & Fuel Cost | - | - | - | - | - |
Electricity & Power | - | - | - | - | - |
Oil, Fuel & Natural gas | - | - | - | - | - |
Coals etc | - | - | - | - | - |
Other power & fuel | - | - | - | - | - |
Employee Cost | ₹1,652 Cr | ₹1,465 Cr | ₹1,014 Cr | ₹536 Cr | ₹370 Cr |
Salaries, Wages & Bonus | ₹1,550 Cr | ₹1,372 Cr | ₹945 Cr | ₹510 Cr | ₹348 Cr |
Contributions to EPF & Pension Funds | ₹35 Cr | ₹34 Cr | ₹24 Cr | ₹10 Cr | ₹7.00 Cr |
Workmen and Staff Welfare Expenses | ₹14 Cr | ₹13 Cr | ₹8.52 Cr | ₹2.23 Cr | ₹5.40 Cr |
Other Employees Cost | ₹53 Cr | ₹47 Cr | ₹37 Cr | ₹14 Cr | ₹9.20 Cr |
Other Manufacturing Expenses | ₹168 Cr | ₹201 Cr | ₹214 Cr | ₹119 Cr | ₹70 Cr |
Sub-contracted / Out sourced services | ₹168 Cr | ₹201 Cr | ₹214 Cr | ₹119 Cr | - |
Processing Charges | - | - | - | - | ₹57 Cr |
Repairs and Maintenance | - | - | - | - | ₹10 Cr |
Packing Material Consumed | - | - | - | - | - |
Other Mfg Exp | - | - | - | - | ₹2.20 Cr |
General and Administration Expenses | ₹243 Cr | ₹224 Cr | ₹137 Cr | ₹75 Cr | ₹43 Cr |
Rent , Rates & Taxes | ₹8.90 Cr | ₹6.60 Cr | ₹11 Cr | ₹6.33 Cr | ₹3.80 Cr |
Insurance | ₹6.30 Cr | ₹4.00 Cr | ₹2.61 Cr | ₹1.95 Cr | ₹1.80 Cr |
Printing and stationery | ₹34 Cr | ₹29 Cr | - | - | - |
Professional and legal fees | ₹63 Cr | ₹64 Cr | ₹50 Cr | ₹28 Cr | - |
Traveling and conveyance | ₹39 Cr | ₹38 Cr | ₹6.44 Cr | ₹0.68 Cr | ₹21 Cr |
Other Administration | ₹91 Cr | ₹83 Cr | ₹67 Cr | ₹37 Cr | ₹16 Cr |
Selling and Distribution Expenses | - | - | - | - | - |
Advertisement & Sales Promotion | - | - | - | - | - |
Sales Commissions & Incentives | - | - | - | - | - |
Freight and Forwarding | - | - | - | - | - |
Handling and Clearing Charges | - | - | - | - | - |
Other Selling Expenses | - | - | - | - | - |
Miscellaneous Expenses | ₹22 Cr | ₹21 Cr | ₹12 Cr | ₹5.96 Cr | ₹17 Cr |
Bad debts /advances written off | - | - | ₹0.51 Cr | - | - |
Provision for doubtful debts | - | - | ₹2.16 Cr | ₹0.68 Cr | - |
Losson disposal of fixed assets(net) | - | - | - | - | - |
Losson foreign exchange fluctuations | - | - | - | - | - |
Losson sale of non-trade current investments | - | - | - | - | - |
Other Miscellaneous Expenses | ₹22 Cr | ₹21 Cr | ₹9.23 Cr | ₹5.28 Cr | ₹17 Cr |
Less: Expenses Capitalised | - | - | - | - | - |
Total Expenditure | ₹2,084 Cr | ₹1,910 Cr | ₹1,378 Cr | ₹736 Cr | ₹499 Cr |
Operating Profit (Excl OI) | ₹505 Cr | ₹396 Cr | ₹287 Cr | ₹231 Cr | ₹144 Cr |
Other Income | ₹76 Cr | ₹58 Cr | ₹26 Cr | ₹31 Cr | ₹3.50 Cr |
Interest Received | ₹23 Cr | ₹9.60 Cr | ₹0.80 Cr | ₹0.89 Cr | ₹0.90 Cr |
Dividend Received | ₹7.10 Cr | ₹0.70 Cr | - | - | - |
Profit on sale of Fixed Assets | - | - | - | - | - |
Profits on sale of Investments | - | - | ₹5.01 Cr | - | - |
Provision Written Back | ₹11 Cr | ₹0.20 Cr | - | - | - |
Foreign Exchange Gains | ₹16 Cr | ₹40 Cr | ₹19 Cr | ₹6.25 Cr | ₹1.90 Cr |
Others | ₹19 Cr | ₹7.90 Cr | ₹1.10 Cr | ₹24 Cr | ₹0.70 Cr |
Operating Profit | ₹582 Cr | ₹454 Cr | ₹313 Cr | ₹261 Cr | ₹147 Cr |
Interest | ₹49 Cr | ₹31 Cr | ₹5.96 Cr | ₹6.96 Cr | ₹8.80 Cr |
InterestonDebenture / Bonds | - | - | - | - | - |
Interest on Term Loan | - | - | - | - | ₹8.80 Cr |
Intereston Fixed deposits | - | - | - | - | - |
Bank Charges etc | ₹3.10 Cr | ₹8.00 Cr | ₹1.29 Cr | ₹1.45 Cr | - |
Other Interest | ₹46 Cr | ₹23 Cr | ₹4.67 Cr | ₹5.51 Cr | - |
PBDT | ₹532 Cr | ₹423 Cr | ₹307 Cr | ₹254 Cr | ₹138 Cr |
Depreciation | ₹76 Cr | ₹60 Cr | ₹33 Cr | ₹26 Cr | ₹19 Cr |
Profit Before Taxation & Exceptional Items | ₹456 Cr | ₹363 Cr | ₹273 Cr | ₹229 Cr | ₹119 Cr |
Exceptional Income / Expenses | ₹2.40 Cr | - | ₹-47 Cr | ₹2.99 Cr | ₹-44 Cr |
Profit Before Tax | ₹459 Cr | ₹363 Cr | ₹226 Cr | ₹231 Cr | ₹75 Cr |
Provision for Tax | ₹122 Cr | ₹97 Cr | ₹64 Cr | ₹46 Cr | ₹26 Cr |
Current Income Tax | ₹126 Cr | ₹90 Cr | ₹95 Cr | ₹47 Cr | ₹33 Cr |
Deferred Tax | ₹-3.60 Cr | ₹6.70 Cr | ₹-31 Cr | ₹-1.35 Cr | ₹-6.40 Cr |
Other taxes | - | - | - | - | - |
Profit After Tax | ₹337 Cr | ₹266 Cr | ₹163 Cr | ₹186 Cr | ₹49 Cr |
Extra items | - | - | - | ₹-36 Cr | ₹-62 Cr |
Minority Interest | - | - | ₹1.94 Cr | ₹-0.01 Cr | ₹6.10 Cr |
Share of Associate | - | - | - | - | ₹0.50 Cr |
Other Consolidated Items | - | - | - | - | - |
Consolidated Net Profit | ₹337 Cr | ₹266 Cr | ₹165 Cr | ₹149 Cr | ₹-6.30 Cr |
Adjustments to PAT | - | - | - | - | - |
Profit Balance B/F | ₹736 Cr | ₹469 Cr | ₹300 Cr | ₹-136 Cr | ₹-128 Cr |
Appropriations | ₹1,073 Cr | ₹735 Cr | ₹465 Cr | ₹14 Cr | ₹-135 Cr |
General Reserves | - | - | - | - | - |
Proposed Equity Dividend | - | - | - | - | - |
Corporate dividend tax | - | - | - | - | - |
Other Appropriation | - | ₹-0.70 Cr | ₹-3.89 Cr | ₹-286 Cr | - |
Equity Dividend % | - | - | - | - | - |
Earnings Per Share | ₹15.17 | ₹12.01 | ₹938.81 | ₹954.66 | ₹-40.26 |
Adjusted EPS | ₹15.17 | ₹12.01 | ₹7.45 | ₹7.58 | ₹-0.32 |
Compare Income Statement of peers of INDEGENE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDEGENE | ₹13,346.4 Cr | -3.8% | 5.3% | NA | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹410,142.0 Cr | -1.5% | 9.1% | 9.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹145,762.0 Cr | -4.9% | -0.6% | 59.1% | Stock Analytics | |
CIPLA | ₹114,322.0 Cr | -1.8% | 1% | 0.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹111,171.0 Cr | 1.6% | 12.1% | 21.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹92,603.7 Cr | -3% | -0.9% | -7.7% | Stock Analytics |
INDEGENE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDEGENE | -3.8% |
5.3% |
|
SENSEX | -2.9% |
3.1% |
1.8% |
You may also like the below Video Courses